Valvular Aortic valve

Pharmacology

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block...

Dr. Juan Manuel Pérez - 15 January, 2026

Learn More

Mitral valve

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis,...

Dr. Omar Tupayachi - 25 December, 2025

Learn More

Structural heart disease

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and...

Dr. Juan Manuel Pérez - 18 December, 2025

Learn More

Structural heart disease

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

This systematic meta-analysis assessed the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with...

Dr. Juan Manuel Pérez - 18 December, 2025

Learn More

Structural heart disease

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to...

Dr. Juan Manuel Pérez - 27 November, 2025

Learn More

Structural heart disease

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to...

Dr. Juan Manuel Pérez - 26 November, 2025

Learn More

Structural heart disease

Transradial Aortic Valvuloplasty: Is Minimalism Worth It?

Balloon aortic valvuloplasty (BAV) has historically been used either as a bridge strategy, an assessment tool, or...

Dr. Omar Tupayachi - 19 November, 2025

Learn More

Structural heart disease

TCT 2025 | SUMMIT-MAC: Transcatheter Mitral Valve Replacement with the Tendyne System in Patients with Severe Annular Calcification

The prospective, multicenter SUMMIT-MAC study evaluated the safety and efficacy of transcatheter mitral valve replacement (TMVR) using...

Dr. Juan Manuel Pérez - 29 October, 2025

Learn More

Is it safe to use negative chronotropic drugs early after TAVI?

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Transradial Aortic Valvuloplasty: Is Minimalism Worth It?

TCT 2025 | SUMMIT-MAC: Transcatheter Mitral Valve Replacement with the Tendyne System in Patients with Severe Annular Calcification

Last News

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Institutional News

Fellow’s Corner 2026 – Submit Your Clinical Case

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

Access